Optometrists and general ophthalmologists field a significant number of geographic atrophy (GA) patients. To ensure patients are promptly referred to retina specialists, Dr. Garg highlights the risk factors that drive this disease, imaging modalities that are best suited for GA evaluation, the type of lesion patterns that place patients at high risk for progression, and potential treatments.
This activity is supported by an unrestricted medical educational grant from Apellis Pharmaceuticals.
Upon completion of this activity, the participant should be able to:
Evolve Medical Education LLC (Evolve) is a COPE-accredited administrator.
This activity, COPE Activity Number 124363, is accredited by COPE for continuing education for optometrists. This course is approved for 1 hour CE.
Course #: 79367-TD
Activity #: 124363
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
Provided by Evolve Medical Education 
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Sunir J. Garg, MD, FACS, FASRS
Professor of Ophthalmology
Thomas Jefferson University and Wills Eye Retina Service
Co-Director of Retina Research and Partner
Mid Atlantic Retina
Philadelphia, PA
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Sunir J. Garg, MD, FACS, FASRS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Allergan, American Academy of Ophthalmology, Apellis Pharmaceuticals, Bausch + Lomb, Boehringer Ingelheim, Kanaph Therapeutics, and Merck Manual. Grant/Research Support: American Academy of Ophthalmology, Apellis Pharmaceuticals, Boehringer Ingelheim, Genentech, NGM Biopharmaceuticals, and Regeneron Pharmaceuticals. Advisory Board: Coherus BioSciences.
The Evolve staff and planners have no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Apellis Pharmaceuticals.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Yewlin E. Chee, MD
Camila Ventura MD, PhD
Edward Wood, MD
Tony Capone Jr, MD
Katherine E. Talcott, MD
Nassim Abreu, MD
Enhancing Collaborative Care in Retinal Diseases: A Focus on Injection Therapies
1.00 creditDeepak Sambhara, MD
Eric D. Donnenfeld, MD
Marjan Farid, MD
Jason J. Jones, MD
Eva I. Liang, MD, FACS
Carlton Yuen, MD
